KNSA STOCK ANALYSIS
Price summary
Last Close
64.53 $
Jul 2, 26
Market Cap
5.3 B $
Q1 2026 (TTM)
52-Week Range
Return and risk cards
Total Return
%+135.2
Volatility
%43.9
Sharpe Ratio
1.26
Sortino Ratio
1.58
Distance to Peak
%0.0
Maximum Drawdown
-%21.1
Seasonality
Seasonality Chart
Periodic Returns
1M
+37.5%
3M
+32.2%
6M
+56.4%
YTD
+56.4%
1Y
+135.2%
3Y
+362.2%
Returns are computed from split-adjusted closes; dividends are not included.
YTD Return — Stock vs Asset Classes
Year-to-dateStock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
Monthly positivity
Monthly Avg Positive/Negative Close
Frequently Asked Questions
What is the current Kiniksa Pharmaceuticals Ltd (KNSA) stock price?
KNSA last closed at 64.53 $ (Jul 2, 26). Price data is refreshed after every trading day.
What is the P/E ratio of KNSA?
Kiniksa Pharmaceuticals Ltd trades at a trailing-twelve-month P/E of 72.79. See the comparison tables on the Peers tab for the industry context.
What is the market capitalization of Kiniksa Pharmaceuticals Ltd?
Kiniksa Pharmaceuticals Ltd (KNSA) has a market capitalization of approximately 5.3 B $ as of the latest reported period.
Who are the main competitors of KNSA?
Key peers of Kiniksa Pharmaceuticals Ltd include Laboratorios Farmaceuticos ROVI, Bausch Health Companies Inc, EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, Haleon PLC. A detailed metric comparison is available on the Peers tab.
Go deeper on KNSA
Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.
